Rituximab Improves Overall Survival in Patients Treated with CODOX-M/IVAC for Burkitt Lymphoma (BL) and B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and BL (BCL-U): A Single Center Experience and Review of the Literature (Articles)
A. Prica, A. Pratzer, M. Cheung, K. Thompson, E. Piliotis, N. L. Berinstein, K. Imrie, R. Pradhan, A. Vyas, Z. Ghorab, D. Good, L. Zhang, R. Buckstein
Journal of Cancer Therapy
Vol.6 No.1,December 26, 2014
DOI:
10.4236/jct.2015.61001
3,723 Downloads 4,523 Views Citations
This article belongs to the Special Issue on
Advances in Lymphoma Research